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 Attempts to certificate ‘clean athlete status’ are scrutinised on multiple grounds. 
 The need for transparency, evidence and scientific scrutiny is highlighted. 
 Clean sport and anti-doping are discussed in the broader scope of sport integrity. 
 Instituting ways to show due diligence in compliance with anti-doping is 
recommended. 
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Athletes, sponsors and sport organisations all have a vested interest in upholding the values of 
clean sport.  Despite the considerable and concerted efforts of the global anti-doping system 
over two decades, the present system is imperfect. Capitalising upon consequent frustrations 
of athletes, event organisers and sponsors, alternative anti-doping systems have emerged 
outside the global regulatory framework. The operating principles of these systems raise 
several concerns, notably including accountability, legitimacy and fairness to athletes. In this 
paper, we scrutinise the Clean ProtocolTM, which is the most comprehensive alternative system, 
for its shortcomings through detailed analysis of its alleged logical and scientific merits. 
Specifically, we draw the attention of the anti-doping community – including researchers and 
practitioners – to the potential pitfalls of using assessment tools beyond the scope for which 
they have been validated, and implementing new approaches without validation. Further, we 
argue that whilst protecting clean sport is critically important to all stakeholders, protocols that 
put athletes in disadvantageous positions and/or pose risks to their professional and personal 
lives lack legitimacy. We criticise the use of anti-doping data and scientific research out of 
context, and highlight unintended harms that are likely to arise from the widespread 
implementation of such protocols in parallel with – or in place of – the existing global anti-
doping framework.  
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As authors, we write to express our concerns regarding a so called ‘certification programme’ – 
the Clean ProtocolTM – that claims to be able to provide proof for athletes that according to 
their protocols they are “clean” athletes. On the Clean ProtocolTM website it states “You pride 
yourself on being a clean athlete. Now there is an easy way to prove it. Get clean certified.”2. 
This promise of proving “clean” status is no doubt appealing to many, given the importance of 
that label to anti-doping stakeholders. When clean sport exists, athletes can contest their 
capabilities within a sport context where outcomes are determined by natural ability, hard work, 
tactics and, to some extent, access to resources and luck (Loland, 2018; Loland & McNamee, 
2019). Whilst it is accepted that doping will never be completely eliminated from sport (Dimeo, 
2016), protecting the rights of athletes to compete in clean sport remains the goal of those 
seeking to protect the integrity of sport and the welfare of athletes.  
 
The World Anti-Doping Agency was established in 1999 to create a global system to promote 
and protect clean sport. It is now widely recognised that a successful anti-doping system cannot 
rely on testing alone. Critiques of the current anti-doping system (e.g., Berry, 2008; Maennig, 
2014; Pielke & Boye, 2019; Pitsch, 2009) tend to focus on the relative (in)effectiveness and 
costs of testing, and imply that an effective anti-doping system only requires political will (e.g., 
Pielke, 2018). Indeed, the complex, stigmatised and deceptive nature of doping behaviours are 
embedded in sporting culture and may involve collusion or complicity of an entourage (Hughes 
& Coakley,1991; Waddington & Smith, 2009). However, in reality, any anti-doping 
programme has to respond to a dynamic and interdependent system, and must overcome 
significant methodological and logistical challenges. An effective response requires a 
multidimensional global solution that encompasses approaches from all relevant research 
disciplines, stakeholders, sponsors and industry partners (Pitsiladis et al., 2019; Viret, 2020a).  
Critical to this whole-system approach (Backhouse et al., 2018) are athletes whose voices have 
been amplified in recent years through a growing number of advocacy groups. 
 
Clean ProtocolTM is an online system designed to enable athletes to prove their adherence with 
anti-doping regulations (i.e., their ‘cleanness’) via an independent and confidential multi-
layered certification process3. In its promotional material it states that “Clean ProtocolTM 
applies the highest anti-doping standards across all disciplines and applies the latest available 
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testing technologies. The technology behind the Clean Protocol™ will screen out those athletes 
and their entourage who are not 100% clean”4. The protocol comprises nine levels (Table 1). 
According to the Clean ProtocolTM website, these segments have been designed on advice from 
a range of experts in psychology, neuroscience, and sports physiology to form what “is the 
most advanced system of clean sports authentication in the world”5. 
 
We concur with the World Clean Sport Organisation (the legal entity behind the Clean 
ProtocolTM) when they state that “Clean athletes deserve credible sport”. Nevertheless, the 
promise that clean status can be ‘achieved’ through compliance with at least seven of the nine 
levels of the proposed “multi-tiered verification of clean sports authentication” – comprising 
behavioural, psychological and physiological indicators of doping – has no scientific evidence 
base. Criticisms of doping-related psychometric tests as diagnostic tools in an earlier iteration 
of the Clean ProtocolTM (Petróczi et al., 2015a, 2015b) holding, we raise further concerns with 
the revised protocol here. 
 
First, we take issue with the concept of a ‘testing’ programme that claims to prove that an 
athlete is clean. It is not possible to prove innocence as it is not possible to prove the absence 
of an unspecified being, act, effect or relationship. For this reason, the presumption of 
innocence is enshrined within universal human rights instruments and is a fundamental 
principle of most legal systems. In the World Anti-Doping Code (WADC), any athlete who has 
not been shown to have committed an anti-doping rule violation (ADRV) is to be considered a 
‘clean athlete’. Thus, Clean ProtocolTM is a product that purports to provide athletes with 
something which is redundant (because they are already entitled to it) and chimerical (because 
it cannot be secured).  
 
Secondly, the Clean ProtocolTM misuses doping-related psychometric instruments. None of the 
listed tests – including those developed by authors of this letter – were designed or validated 
for diagnostic purposes. These measures do not represent proxies for doping behaviour 
(Petróczi & Aidman, 2009, Gucciardi et al., 2010) or broader unethical conduct in sport (i.e., 
Boardley & Kavussanu, 2008). Inferring doping from attitudinal measures is problematic. In 
two meta-analyses it has been shown that attitude is not a noteworthy predictor of doping 
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(Ntoumanis et al., 2014; Blank et al., 2016).  Even with research showing that athletes who 
admitted doping exhibit more lenient attitudes toward doping, all athletes generally express 
negative doping attitudes, including confessed users (Petróczi et al, 2010; 2011). Of course, 
those who deny doping can successfully create an attitudinal profile consistent with ‘clean’ 
status. 
 
Furthermore, it is unclear how the proposed cut-off values for scores derived using these 
measures are to indicate ‘clean’ status, or how these were established. This element was 
challenged five years ago (Petróczi et al., 2015a; 2015b). Similarly, social desirability tests 
(e.g., Crowne & Marlowe, 1960; Paulus, 1989; Stoebel, 1999) are designed to assess propensity 
for impression management and/or socially desirable responses, and should be co-administered 
with other psychometric scales (Leite & Nazari, 2017; Holden & Flekken, 2017; Paulhus, 2017; 
Perinelli & Gremigni, 2016). They are not intended for individual diagnostic purposes. 
 
Thirdly, instruments based on Event Related Potential (ERP) such as deception-detectors (e.g., 
Ben-Shakhar, 2012; Cook et al., 2012; Gamer & Pertzov, 2018), or latency-based 
measurements such as the autobiographical Implicit Association Test (aIAT, Agosta & Sartori, 
2013) or the Concealed Information Test (Vershchuere et al., 2010), are also problematic as 
utilised by the Clean ProtocolTM. Physiological changes, oculomotor measures (e.g., eye 
movements, blinks or duration of focus) and response-time differences can be induced and 
captured, but the underlying mechanisms behind these changes are poorly understood (Petróczi 
et al., 2015a; 2015b; 2013; Verschuere et al., 2009). Unless any other explanations for the 
changes observed during these assessments can be ruled out, making causal inferences 
regarding deception is unjustified (Leonetti, 2017). Moral cognition (e.g., thoughts about 
cheating by doping) presents further complication, because cultural and linguistic variables are 
not controlled (Moll et al., 2005). In summary, deception detection technologies present serious 
practical, regulatory and ethical challenges (Iacono & Ben-Shakhar, 2019; NRC, 2003; 
Shamoo, 2010) to the Clean ProtocolTM.  
 
Fourthly, their stated sharing of biological data from the Athlete Biological Passport (ABP) is 
problematic for two reasons: (1) only the haematological variables of the ABP are available to 
athletes, not the full passport profile and (2) ABP parameters cannot be interpreted without 
understanding the context of sample collection. Factors such as high altitude training, exercise, 




conditions can alter ABP parameters (e.g., Amante et al., 2019; Coffman et al., 2020; Miller et 
al., 2019; Mullen et al., 2020; Voss et al., 2020; Robinson et al., 2011; 2016). Expert knowledge 
and proficiency have a bearing on interpretation of ABP data too (Schumacher & d′Onofrio, 
2012). The absence of anonymity in review introduces the potential for reviewer bias, which 
is precisely the reason why in the ABP the expert reviewing the passport does not know the 
identity of the athlete. It is true that the current markers of both the haematological and steroid 
modules of the ABP can be used to develop target testing when the profile of a specific athlete 
is particularly abnormal (Robinson et al., 2017; Zorzoli et al., 2014) and - in conjunction with 
other data - have been linked to or been the basis of sanctions (Faiss et al., 2019). Nevertheless, 
the interpretation of the ABP data may facilitate a range of non-doping explanations for the 
observed biomarker values. In the present regime, athletes are given the opportunity to provide 
explanations after being notified of adverse passport findings. The validity of explanations 
arising from the Clean ProtocolTM is limited to the context of ABP sample collection and cannot 
be generalised from. 
 
Furthermore, the absence of evidence of doping manipulation in an ABP cannot, on its own, 
confer clean status. When considering blood doping, a comparison of ABP-driven sanctions to 
population prevalence estimates (e.g., Faiss et al., 2020; Sottas et al., 2011) suggests that the 
present system produces a large number of false negative results. In every analytical approach, 
in order to increase the specificity of a result (to avoid false positives), there is always a price 
to pay in term of sensitivity. This is appropriate in a disciplinary context, in which the 
prosecuting authority’s primary concern must be to avoid sanctioning the ‘innocent’. In 
addition, whilst the ABP is longitudinal in nature, it does not provide continuous coverage of 
the athlete’s biomarker values, only a snapshot of biomarker values at the time of data 
collection. Unless an athlete is sampled at a continuous rate, it would be impossible to conclude 
whether an athlete is truly clean or not. Moreover, ABP data can also be used to aid doping 
practices thus making large sets of personalised ABP data available to third party or making 
the data publicly available might have the unintended consequence of aiding doping, which is 
mitigated by sharing partial ABP data and delayed data disclosure (Devriendt et al., 2018).  
Because of the delayed disclosure, athletes sharing their ABP data as per the Clean ProtocolTM 
reflects the past, not the present status. 
 
Fifthly, there are several ethical concerns with the Clean ProtocolTM. In the 1980s, scholars had 




widespread, and if drug use is believed to enhance performance, such use can have destructive 
coercive effects. There is a parallel logic with the Clean ProtocolTM. If the use of tools such as 
the Clean ProtocolTM is taken up among sponsors, commercial event organisers and athletes, 
those who do not wish to engage in this practice may unwittingly become suspects of doping. 
In fact, if any protocol becomes a new norm, a kind of expected ‘label’ to have, suspicions fall 
on those without the putatively approved ‘label’. This coercive pressure will extend to medical 
data in/directly derived from either the ABP or Therapeutic Use Exemption Certificates. This 
would be in tension with medical professionals’ commitment to (athlete) patient confidentiality 
(Cox et al., 2017).  
 
A further ethical concern relates to the potential for misuse of athletes’ data. As is evident from 
what is said above, the Clean ProtocolTM intends to utilise methods and resultant data outside 
the intended and validated purpose (e.g., psychometric assessment), without the critically 
important context (e.g., ABP data) and without any prior testing or validation of the method to 
doping (e.g., oculomotor deception detection). The logic of science is not to prove hypotheses 
but to examine whether a hypothesis can stand up to the toughest possible attempts of 
falsification (Popper, 1963). Thus, in anti-doping research the idea cannot be to prove that 
athletes are clean, but to test whether the hypothesis of negative or positive controls stands up 
to the highest standards of critical scrutiny. Concepts such as the Clean ProtocolTM fail on both 
ethical and scientific grounds.  
 
Sixthly, the interplay between the Clean ProtocolTM and the World Anti-Doping Programme 
legal framework requires close scrutiny. The Clean ProtocolTM website claims that it is 
“designed so that there is no reason why a clean athlete would not take the Clean Protocol™”. 
The following claims are made: “no risk for clean athletes”; “significant benefits and no 
greater detriment to athletes”. On the other hand, the Clean ProtocolTM claims to be working 
hand-in-hand with anti-doping organisations in various, unspecified ways. They assert: “If that 
[failing the Clean ProtocolTM tests] led the World Clean Sport Organisation (WCSO) to believe 
the Clean ProtocolTM had been breached then those findings would be shared with other anti-
doping agencies for follow up action”.  Precisely which anti-doping agencies would follow up 
is unspecified, and so critical questions concerning legitimate authority, sanctioning powers 
and data sharing agreements are elided. By contrast, the WADC operates such that the burden 
of proof is on anti-doping organisations to establish an ADRV. Thus, at least until a positive 




tangible evidence of an ADRV), the default assumption is that all athletes are ‘clean’. By 
implying that athletes must proactively demonstrate that they are ‘clean’, the Clean ProtocolTM 
may generate apparent reputational credit, but from a legal perspective provides athletes with 
no more than they are already guaranteed.  
 
The concept of ‘clean athlete’ that the Clean ProtocolTM promises to certify has no basis in the 
WADC and eludes legal definition (Viret, 2020a). Reliance on psychometric testing or signing 
commitments (the “Clean Contract”), for example, presupposes that the clean athlete is an 
athlete who is not deliberately engaging in ‘doping’. This, however, does not fit in well with 
the current regulation, under which ADRVs occur when an athlete is found to have, objectively, 
a prohibited substance in their sample or when there is sufficient evidence that a prohibited 
substance or method was used (Viret, 2020b). Any legally binding statement that athletes could 
volunteer that they are ‘not doping’ is problematic, given that the WADC relies on strict 
liability for ADRVs and presumed fault for disciplinary sanctions. The Clean ProtocolTM 
informs athletes that they should submit “if you are 100% confident that you will not dope 
yourself or others and will abide by the rules of the sport and the WADA Code”. This is 
something that no athlete is able to guarantee under the current regulatory framework, and 
implying otherwise is misleading and potentially damaging for the athlete. The suggestion in 
item eight of the Clean ProtocolTM, that athletes may agree to sign a statement that may come 
under sanction of perjury and possible criminal consequences in some jurisdictions, appears of 
particular concern in this regard. 
 
The Clean ProtocolTM states that, even where the athlete is facing sanctions owing to 
inadvertent or third party induced doping, the protocol “could be very helpful information to 
assist with sentencing” in their defence. This unprecedented assertion plays to the idea that 
athletes could produce their Clean ProtocolTM data to prove no (significant) fault, and thus 
avoid/reduce an otherwise applicable sanction. It is highly questionable whether such a promise 
would be acceptable to any disciplinary panels, let alone the Court of Arbitration for Sport 
(CAS), which is sports’ final court of appeal. 
 
Given the issues that we pointed out with respect to the validation of the techniques used in the 
Clean ProtocolTM, it is questionable how much evidentiary value panels would assign to this 
type of evidence. Previously faced with lie detector evaluations, CAS panels have been 




2016/A/4534, Villanueva v. FINA, award of 16 March 2017). As already highlighted in 
connection with lie detector evidence (Rigozzi & Quinn, 2014; Viret, 2016), the collateral risk 
of, over time, making non-participating athletes the object of suspicion for their mere refusal 
to subject themselves to the protocol is more credible than the hypothetical benefit asserted. 
 
In order to support prosecution, proof of an ADRV rests on the anti-doping organisation, to the 
standard of comfortable satisfaction (Article 3.1 of the WADA Code). This standard is higher 
than the balance of probability standard that the defence must meet (Ioannidis, 2015). 
Furthermore, the WADC and CAS jurisprudence (Ioannidis 2016; 2017), as well as national 
case law, clearly instruct that the more serious the allegation, the stronger the evidence required 
(CAS 2004/O/645 USADA v. Montgomery; Hornal v Neuberger Products Ltd [1957] 1 QB 
247). Creators of the Clean ProtocolTM are not able to provide valid scientific evidences to 
support their “alternative non-analytical approach” to anti-doping. It is highly unlikely that a 
“suspicious profile” would be recognised by CAS as sufficiently reliable circumstantial 
evidence. The defence could easily undermine the scientific validity of the tools and thus their 
probative value.  
 
Seventhly, in addition to the ethical concerns above, due legal consideration must be given to 
privacy (Macgregor et al., 2013). In addition to ‘whereabouts’ and the timeframe of 
professional contracts, much of the data collected from the athletes would qualify as ‘sensitive’ 
health data (e.g., ABP data, injuries and TUE) which enjoy special protection under data 
protection laws, and specifically, in the European context, under the General Data Protection 
Regulation (GDPR). Though processing of all data can generally be legitimised through 
consent, such consent needs to be informed, explicit and free, which includes the right to 
withdraw consent at any time. The problematic character of consent in this context is a 
commonplace (Viret, 2016, 2019).  Clean ProtocolTM advocates for the protocol to become part 
of the anti-doping arsenal, including its use by teams, sponsors or event organisers, and that 
suspicious findings may be communicated to anti-doping organisations. If the Clean 
ProtocolTM certification were to be endorsed or even implemented by sports organisations 
within their anti-doping programs (so that athletes who do not submit to the Clean ProtocolTM 
start appearing suspicious a priori) considerable issues arise regarding the validity of the 
consent at hand. Clean ProtocolTM does not explain its protections of data subject rights in this 
highly sensitive legal landscape. Even if we assume that data protection is detailed in the Clean 




evidential differentiations (i.e., the Clean ProtocolTM may be able to operate lawfully in some 
jurisdictions and not in others), creating unequal treatment among athletes and offending the 
main premise of the WADC (WADA, 2021a), which is global harmonisation. 
 
Eighthly, the proposed ‘WhoaboutsTM’ system by which athletes would be required to (en)list 
their support network, supply information on injuries, chronic illnesses and Therapeutic Use 
Exemptions, as well as sponsorship contacts details, collectively introduces a higher level of 
surveillance. The existing WADA whereabouts system is not without criticism (e.g., Møller, 
2011) yet can be justified on the need for out-of-competition testing (MacGregor et al., 2013), 
and has been upheld by the European Court of Human Rights (ECHR Decision, 18 Jan 2018, 
FNASS et al. v France, n° 48151/11 et 77769/13).  The proposed ‘WhoaboutsTM’ also requires 
the athletes’ entourage to subject themselves at least to part of the Clean ProtocolTM tests 
(including various attitudinal measures). Psychological research has demonstrated that the 
entourage (which may include coaches, parents, physiotherapists and physicians) influences 
motivational climate (Petróczi & Aidman, 2009; Ntoumanis et al., 2017) and moral 
disengagement (Boardley & Kavussanu, 2008), which are two important factors in doping. 
Sociological research also shows that the entourage has a strong influence on deviance 
processes (Aubel & Ohl, 2014; Hughes & Coakley, 1991) and that sport organisations play 
direct and indirect roles in doping (Houlihan, 2002). Nevertheless, claiming that the Clean 
ProtocolTM can ‘achieve the transparency required for clean sport’ by disclosing the name of 
their entourage is, at the best, redundant with the article 2.10 of the 2015 WADC on ‘Prohibited 
Association’. The ‘WhoaboutTM’ gives the illusion that naming people who supports the athlete 
in training and competition, if done honestly, is enough to be able to assess the role of complex 
interactions between an athlete and his/her entourage. Such lists can be used to inform targeted 
testing (for which the organisation behind the Clean ProtocolTM has no authority), but its 
usefulness to be an effective prevention tool is limited and its application may lead to breaches 
of data protection regulation. At the very least, the ‘WhoaboutTM’ system requires athletes to 
communicate personal data concerning third parties, regardless of their consent, making this 
requirement illegal and unethical. In addition, it is unclear how any data provided could be 
verified without the involvement of national law enforcement authorities, which would make 
any meaningful use either impracticable or disproportionately intrusive. 
 
Ninthly, setting aside the fact that absence (of doping or rule breaking) cannot be proven, only 




‘guilt’ should be upheld.  Therefore, the Clean ProtocolTM should demonstrate that the proposed 
number and combination of indicators listed are sufficient and absolutely necessary to detect 
dopers. 
 
Furthermore, the lack of consideration of anti-doping education is concerning. The Athletes' 
Anti-Doping Rights Act (WADA, 2020) states that “making sure athletes have rights, that 
athletes are aware of those rights, and can exercise those rights is vital to the success of clean 
sport” (p2). Article 7 of this Act include Right to Education: “Athletes have the right to receive 
anti-doping Education and information from Anti-Doping Organizations. (Code Article 18, 
International Standard for Education)” (WADA, 2021b, p6). Fostering a clean sport 
environment needs more than education about the rules and responsibilities (Backhouse, 2015) 
but minimally, the Clean ProtocolTM should specify what educational provisions support their 
would-be clean sport authentication system.   
 
Whilst this commentary is primarily concerned with the Clean ProtocolTM, the issue of 
certification of ‘clean athlete’ status is not unique to them. It is also seen in programmes such 
as the Mouvement Pour un Cyclisme Crédible (MPCC; http://mpcc.fr/index.php/en/), 
QUARTZ (www.quartzprogram.org) and Clean Sport Collective (www.cleansport.org). These 
programmes vary considerably in their approach. MPCC, created to advocate clean cycling, 
tries to involve teams and riders, on a voluntary basis, to change the image and culture of 
cycling (Plassard et al., 2020). Clean Sport Collective also relies on an ethical commitment and 
the wish to protect clean athletes. QUARTZ is more ambivalent, as some of its statements are 
close to the Clean ProtocolTM. Thus, these programmes range from asking athletes to make a 
voluntary pledge (i.e., Clean Sport Collective, MPCC) to sharing their personal records from 
the WADA Anti-Doping Administration & Management System and making biological data 
from doping control tests publicly available (i.e., QUARTZ). We welcome programmes that 
encourage athletes to openly declare their commitment to clean sport – as seen with the Clean 
Sport Collective – but we take issue with programmes that lack transparency and scientific 
scrutiny to prevent potential misuse of assessment tools for intents other than their intended 
and validated purpose, and we openly challenge the flawed promise of verifying ‘clean athlete 
status’. Moreover, we call for transparent and rigorous scientific scrutiny via peer-review for 
alternative anti-doping systems. To make constructive progress in the common goal of clean 





1. Transparent and evidence-informed programmes: To facilitate proper use of science, and 
gain credibility among anti-doping stakeholders, we encourage custodians of anti-doping 
systems to:  
a. devise a rigorous and ethically approved study protocol to empirically validate their 
proposed approach and combination of measurements, via publication as a research 
protocol before data collection commences;  
b. publish the results of this study or series of studies in peer-reviewed scientific journal/s 
which would constitute an essential prerequisite for upholding the clean athlete proof 
claims, and clarify the rate of false positives and false negatives; and 
c. via the established mechanism of identifiable authorship, the scientific team behind 
suggestions for any new anti-doping measures should take public responsibility for the 
claims they make.  
 
This level of transparency and scientific scrutiny is fundamental before implementing a 
system that can have serious consequences for the livelihoods of athletes and their 
entourage, and impact their personal lives as well as their rights. 
 
2. Policy guidance on the use of psychometric tests in anti-doping: An argument for 
establishing a robust and peer-reviewed collection of valid and reliable instruments in anti-
doping has been made (Petróczi et al., 2015a). With the increased demands on anti-doping 
organisations and sport federations to evaluate the effectiveness of anti-doping education 
programmes, there is an even more compelling reason for a curated set of psychometric 
assessment with guidance for proper implementation.  
3.  Legal assessment of the tools proposed: Any programme that advertises itself to athletes 
as a way of showing their commitment to ‘clean sport’ and involves collecting data, 
including sensitive data, must undergo assessment for its compliance with data protection 
laws and privacy principles. If it is to offer athletes any added value, it must also be 
designed to be coherent with the mandatory WADC framework when it comes to the 
definition of ‘doping’ or to the proof regime. Athletes should not be lulled into a false 
sense of security and be led to believe that participation could avert anti-doping 
proceedings or give them better cards in such proceedings. Tools allowing athletes to 




medication or supplement check procedures) would appear legally much more acceptable 
and should be given preference over the unrealistic goal of trying to prove clean status. 
4. Collaboration among stakeholders and regulatory bodies to address integrity issues in 
sport collectively:  If ‘clean sport’ is conceptualised as a key rampart of the broader 
concept of sport integrity (Cleret et al, 2015), addressing forms of cheating other than 
doping is not only logical but desirable. If ‘clean sport’ is important because it is a critical 
product attribute for the general public, sponsors, investors and private event organisers, 
its scope ought not to stop at doping but should also include broader integrity issues such 
as age manipulation, tampering with equipment, classification fraud in para-sport, and 
manipulating performance for betting purposes. Ultimately, organised doping (e.g., 
trafficking, supplying and/or administering doping substances, or aiding athletes to avoid 
testing or detection) has been connected to other forms of infringements (e.g., performance 
or competition manipulation or other forms of cheating). Recognising this 
interdependence, some sport (e.g., athletics and tennis) and countries (e.g., Australia, 
Canada, UK) have established integrity units. 
In closing, we understand that the mere existence of the Clean ProtocolTM and similar initiatives 
signals that athletes who compete within the rules and spirit of clean sport, due to a loss of 
confidence in sports, are desperate to show their clean status. Clean ProtocolTM presenting itself 
as an “organisation providing data driven services to improve the credibility of sport”, seems 
to fit well with the “Olympic Agenda 2020” that places credibility as IOC’s main priority for 
the sake of the athletes. Credibility is a central component of trust (Manning, 2000). Even 
though the stated intention of Clean ProtocolTM is to restore trust in sport, we believe that it is 
more likely to instil distrust among athletes. Athletes who stay away from the Clean ProtocolTM 
for reasons independent of doping, such as concern about publicly sharing personal health 
information or contract details, can lose trust of the audience or undeservedly suffer a bad 
image, and the dubious “clean labelling” could create discrimination in access to work.  
 
Unfortunately, sport organisations’ ambivalent moral commitment (Henne, 2014), doubts 
concerning WADA’s effectiveness (Houlihan & Hanstad, 2019; Hoberman, 2013; Wagner & 
Pedersen, 2014), negative outcomes of anti-doping (Read et al., 2018) and stakeholder 
misconduct (Waddington & Smith, 2009) undermined the credibility of anti-doping. Owing to 
the limitations in doping testing, it is impossible to give failproof reassurance to the public that 




promises this is promoting falsehood. As for other opaque and complex contexts, the Clean 
ProtocolTM stages itself as a “judgment device” (Karpik, 2010), to be able to guide the audience 
by claiming to identify clean athletes. To be efficient, a judgment device must be transparent 
and trustworthy.  
 
Despite the claims made by the Clean ProtocolTM, there is no way scientifically to prove that 
one has not doped, only that one is or seeks to be anti-doping rule compliant. The mere absence 
of a positive test for doping does not constitute proof of anything. The current application of 
the principles of strict liability and presumed fault, and the process by which WADA seeks to 
effectively prosecute alleged offences, have a strong legal basis, and endorse athletes’ personal 
responsibility. We believe that alternative initiatives must be underpinned by more credible 
goals and lawful foundation, such as providing athletes with the means to show due diligence 
in compliance with anti-doping regulations. Notably, this mandates knowledge of the 
Prohibited List, awareness of possible sources for inadvertent doping (contaminated and 
adulterated supplements, etc.), education about how to mitigate the risks in this respect, and 
about what other conducts are prohibited under the WADC (whereabouts failures, refusal to 
submit to testing, etc.). Underpinning personal responsibility, athletes must be educated in 
relation to all relevant aspects anti-doping (WADA, 2020b). We believe that athletes and other 
users must also be cognisant of the details and potentials risks associated with any alternative 
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Table 1: Levels of the Clean ProtocolTM (based on: http://cleanprotocol.org/the-clean-
protocol/how-it-works, accessed on 14/10/2020)  
 










Requires the athlete to make a contractual commitment to 
abide by the rules of the sport and to submit themselves to the 
Clean Protocol™. 
WhoaboutsTM Requires the athlete to make full disclosure of all of the 
people he/she works with to achieve their sports performance. 
These include coaches, trainers, doctors, physiotherapists, 
sports scientists, team manager, training partners and family 
members (if they are involved in the athlete’s training). 
Entourage Requires the athlete’s entourage to take the Clean Protocol™ 
and make the same commitment as the athlete. 
Biological data Requires the athlete to publish his/her biological data that 
he/she is in possession of as a result of compliance with the 
biological passport or from their own testing from other 
sources. 
Intelligence Requires the athlete to disclose information on event 
schedule, injuries, the use of supplements and any 
Therapeutic Use Exemptions to improve the “targeting of 
random testing under the Clean Protocol™”. 
Psychometric 
testing 
Requires the athlete (and entourage) to take a battery of 
psychometric assessments (e.g., doping attitude, moral 
disengagement, social desirability). 
Deception testing Requires the athlete to take a deception / concealment of 










The athlete may be asked to execute a legally binding 






The athlete may be asked to undertake an FMRI deception 
test measures brain activity by changes in the blood flow 
from the difference in brain activity associated with truth 
telling versus deception. 
 
 
